Fluticasone Propionate, 100 µg bid, Using a Non-CFC Propellant, HFA 134a, in Asthmatic Children

Fluticasone Propionate, 100 µg bid, Using a Non-CFC Propellant, HFA 134a, in Asthmatic Children

BACKGROUND: Secondary to phasing out chlorofluorocarbons (CFCs), the fluticasone propionate (FP) pressurized metered-dose inhaler has been formulated in a nonozone-depleting propellant, hydrofluoralkane (HFA) 134a.

Bibliographic Details
Main Authors:	Brian Lyttle, John Gillies, Maarja Panov, Andrzej Emeryk, Claire Wixon
Format:	Article
Language:	English
Published:	Hindawi Limited 2003-01-01
Series:	Canadian Respiratory Journal
Online Access:	http://dx.doi.org/10.1155/2003/627531

Similar Items

An Investigation of Solute Solubility in the Propellant HFA-134a
by: Hoye, Julie Annalisa
Published: (2007)

Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma
by: Yoxall Sally, et al.
Published: (2007-07-01)

Nanoparticle formulations in HFA propellants
by: Ridder, Kristin Barbara
Published: (2004)

Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
by: Harsha H Kariyawasam, et al.
Published: (2010-06-01)

Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01)

Lack of Systemic Side Effects of Long-Term Inhaled Fluticasone Propionate Use in a Cohort of Asthmatic Children
by: F. Angelini, et al.
Published: (2013-01-01)

Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy
by: Horiuchi K, et al.
Published: (2016-03-01)

The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials
by: Xiaofen Jin, et al.
Published: (2020-01-01)

Fluticasone propionate raises IOP in susceptible individuals
by: Sihota Ramanjit, et al.
Published: (2004-01-01)

Effects of fluticasone propionate on arachidonic acid metabolites in BAL-fluid and methacholine dose-response curves in non-smoking atopic asthmatics
by: S. E. Overbeek, et al.
Published: (1996-01-01)

The efficacy of fluticasone propionate nebulizer therapy in children with laryngotracheitis
by: Лариса Михайлівна Станіславчук
Published: (2015-08-01)

Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
by: Lin-Yu Kuo, et al.
Published: (2010-02-01)

Degradation rates and products of fluticasone propionate in alkaline solutions
by: Tadakazu Tokumura, et al.
Published: (2017-10-01)

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma
by: Woodcock Ashley, et al.
Published: (2007-09-01)

Fluticasone propionate for external use: pharmacological properties and clinical effectiveness
by: E. V. Dvoriankova
Published: (2021-06-01)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
by: Belchamber KBR, et al.
Published: (2018-09-01)

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
by: Sohal SS
Published: (2017-12-01)

Montelukast added to fluticasone propionate does not alter inflammation or outcomes
by: Djukanović, Ratko, et al.
Published: (2010)

Clonidina como medicação pré-anestésica em facectomias: comparação entre as doses de 100 µg e 200 µg La clonidina como medicación preanestésica en facectomías: comparación entre las dosis de 100 µg y 200 µg Clonidine as pre-anesthetic medication in cataract extration: comparison between 100 µg and 200 µg
by: José Roquennedy Souza Cruz, et al.
Published: (2009-12-01)

A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma
by: Andrzej Emeryk, et al.
Published: (2016-08-01)

Efficacy of fluticasone propionate ointment 0.005% in childhood lichen planus
by: Abhinav Kumar, et al.
Published: (2020-01-01)

Inhaled fluticasone propionate impairs pulmonary clearance of <it>Klebsiella Pneumoniae</it> in mice
by: Patterson Craig M, et al.
Published: (2012-05-01)

Preparation of nanosized Fluticasone Propionate nasal spray with improved stability and uniformity
by: Dai Jiajia, et al.
Published: (2015-01-01)

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
by: Barbara P Yawn, et al.
Published: (2010-06-01)

Nongenomic Effects of Fluticasone Propionate and Budesonide on Human Airway Anion Secretion
by: Hasegawa, Yoshinori, et al.
Published: (2012)

Fluticasone propionate/formoterol for COPD management: a randomized controlled trial
by: Papi A, et al.
Published: (2017-07-01)

Comparative Study of Topical Treatment in Allergic Rhinitis Using Azelastine and Fluticasone in a Combination Verses Fluticasone Propionate Alone
by: Raisha G. Dalvi, et al.
Published: (2019-04-01)

Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
by: Louis-Philippe Boulet, et al.
Published: (2004-01-01)

Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells
by: Berger WE, et al.
Published: (2020-05-01)

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma
by: Roberto W. Dal Negro, et al.
Published: (2018-09-01)

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
by: Nina Maria Ainali, et al.
Published: (2020-08-01)

Comparison of Effectiveness in Ciclesonide and Fluticasone Propionate on Small Airway Function in Mild Asthma
by: Makoto Hoshino
Published: (2010-01-01)

Lost in the Mist: Acute Adrenal Crisis Following Intranasal Fluticasone Propionate Overuse
by: Arturo Loaiza-Bonilla, et al.
Published: (2010-01-01)

In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytes
by: Gabriele Di Lorenzo, et al.
Published: (2002-01-01)

Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
by: Marina G. Dogbe, et al.
Published: (2019-10-01)

Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
by: Louis-Philippe Boulet, et al.
Published: (2000-01-01)

Comparative Evaluation of 25µg and 50µg of travaginal Misoprostol for Induction of Labor
by: Buddhi Kumar Shrestha, et al.
Published: (2013-06-01)

The Addition of Salmeterol 50 µg Bid to Anticholinergenic Treatment in Patients with COPD: A Randomized Placebo Controlled Trial
by: Kenneth R Chapman, et al.
Published: (2002-01-01)

Comparison of Effectiveness between Beclomethasone Dipropionate and Fluticasone Propionate in Treatment of Children with Moderate Asthma
by: Akefeh. Ahmadiafshar, et al.
Published: (2010-01-01)

Cannot write session to /tmp/vufind_sessions/sess_slqn2crohj3o3aahriktrghta5